FDA Clears Sekisui Diagnostics Rapid COVID-19 and Flu A&B Combo Test
The CLIA-waived test detects and differentiates SARS-CoV-2, influenza A, and influenza B from a single nasal swab for point-of-care use.
The CLIA-waived test detects and differentiates SARS-CoV-2, influenza A, and influenza B from a single nasal swab for point-of-care use.
Industry experts predict clinical diagnostics will continue evolving in the wake of COVID with automation, AI, and decentralized testing.
Researchers identified key SARS-CoV-2 mutations that increased the virus’ ability to spread via a novel genomic surveillance model.
Investigators have developed an AI tool to analyze electronic health records, helping clinicians identify cases of long COVID.
Read MoreThe AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
Read MoreNasal autoantibodies can predict COVID severity, providing insights for personalized treatment and applications for other respiratory viruses.
Read MoreResearchers developed a new surveillance technique that can detect emerging COVID variants before they become widespread.
Read MoreHealgen Scientific’s Rapid Check COVID-19/Flu A&B Antigen Test received FDA De Novo authorization for OTC use.
Read MoreThe new testing system uses Janus particles to rapidly detect viral proteins, with potential applications extending beyond COVID.
Read MoreHealgen Scientific launched the manufacturing facility to help produce the Healgen Rapid Check COVID-19/Flu A&B Antigen Test.
Read MoreThe landscape of respiratory virus testing has evolved rapidly, driven by burgeoning diagnostic solutions like multiplex testing.
Read MoreA new study found routine lab tests may not effectively diagnose long COVID, underscoring the need for new biomarkers and diagnostic tools.
Read MoreResearchers have developed a bioelectric device using biomembranes to quickly detect and classify harmful variants of coronavirus.
Read MoreWatmind USA received FDA Emergency Use Authorization for its rapid OCT SpeedySwab Covid + FLU A&B Self-Test.
Read MoreA new study found that at-home antibody tests can effectively detect inadequate COVID immunity, aiding decisions about booster vaccinations.
Read MoreThe FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MoreiHealth Labs received FDA Emergency Use Authorization for its COVID-19/Flu A&B Rapid Test Kit, enabling quick self-testing at home.
Read MoreThe lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.
Read More